Isoquinoline compounds
US7470787B2 · kind B2 · utility
46Cited by
8References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 11, 2006 |
| Grant date | Dec 30, 2008 |
| Priority date | — |
| Expiry date | Aug 4, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Isoquinoline compounds with G are provided that influence, inhibit or reduce the action of a G-protein receptor kinase. Pharmaceutical compositions including therapeutically effective amounts of the isoquinoline compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, osteoporosis and glaucoma are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.